Nuvelo (Nasdaq: NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (268)	7/8/2003 10:24:07 PM
From: SemiBull	Read Replies (1) of 286

Nuvelo files $50 million mixed shelf with SEC Tuesday July 8, 3:38 pm ET WASHINGTON, July 8 (Reuters) - Pharmaceutical company Nuvelo Inc. (NasdaqNM:NUVO - News) filed on Tuesday with the U.S. Securities and Exchange Commission (News - Websites) to periodically sell up to $50 million in debt and stock. Net proceeds from the sale will be used for general corporate purposes, including capital expenditures, the company said in a shelf registration statement. Under such a filing, a company may sell securities in one or more offerings, with the terms and conditions determined at the time of sale. Nuvelo shares traded 15 cents lower Tuesday afternoon at $2.00 on the Nasdaq Stock Exchange.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next